| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Clinically Validated Genetic Screening for Familial Hypercholesterolemia in Quebec
|
Guerin, Amanda
|
|
|
16 |
3S |
p. e53-e54
|
article
|
| 2 |
A Complex Case: Patient with Elevated Lp(a) and Debilitating Stroke
|
Soffer, Daniel
|
|
|
16 |
3S |
p. e44
|
article
|
| 3 |
Acquired Chylomicronemia Due to Autoantibodies Against GPIHBP1
|
Katkar, Mansi
|
|
|
16 |
3S |
p. e46-e47
|
article
|
| 4 |
†A Cross-Study Comparison Investigating the Effect of CSL112 (Apolipoprotein A-I [Human]) on Cholesterol Efflux Capacity (Encore ACC 2022)
|
Goto, Shinya
|
|
|
16 |
3S |
p. e54-e55
|
article
|
| 5 |
*A Novel ABCG8 Variant and Apo(A) Short Isoform Associated with Premature Atherosclerosis and Familial Hypercholesterolemia Phenocopy.
|
Omar, Alaa
|
|
|
16 |
3S |
p. e48-e49
|
article
|
| 6 |
*An Unsolved Case: FH or Sitosterolemia?
|
Ayers, Michael
|
|
|
16 |
3S |
p. e43-e44
|
article
|
| 7 |
A Randomized Study to Evaluate the Effect of an Inclisiran First Implementation Strategy vs Usual Care in Patients with ASCVD and Elevated Low-density Lipoprotein Cholesterol: Rationale and Design of the VICTORION-INITIATE Trial
|
East, Cara
|
|
|
16 |
3S |
p. e67
|
article
|
| 8 |
Association Between Dietary Fat Content and Serum Lipoprotein(a) Level
|
Patel, Nimai
|
|
|
16 |
3S |
p. e62
|
article
|
| 9 |
Association between Metabolic Syndrome and Pulmonary Arterial Hypertension
|
Park, Kyeeun
|
|
|
16 |
3S |
p. e71
|
article
|
| 10 |
Association of Coronary Events with Burden and Distribution of Coronary Artery Calcification: Results from the Multi-Ethnic Study of Atherosclerosis
|
Allen, Tara Shrout
|
|
|
16 |
3S |
p. e47-e48
|
article
|
| 11 |
Association of Systemic Inflammation with Lipid Profiles and Management in Patients with Rheumatoid Arthritis
|
Kim, Yoo Jin
|
|
|
16 |
3S |
p. e58-e59
|
article
|
| 12 |
Barriers and Facilitators to Identification, Cascade Testing, and Treatment for Familial Hypercholesterolemia: A Scoping Review
|
Calvo, Evan
|
|
|
16 |
3S |
p. e35-e36
|
article
|
| 13 |
Characterization of Inclisiran Use in Real World: Prescription Data from Germany
|
Klebs, Sven
|
|
|
16 |
3S |
p. e73-e74
|
article
|
| 14 |
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset
|
McGowan, Mary
|
|
|
16 |
3S |
p. e36-e37
|
article
|
| 15 |
Comparing Prescribing Practices of Statin Therapy in Atherosclerotic Cardiovascular Disease Patients with Varying Levels of Chronic Kidney Disease
|
Lowe, Rachel
|
|
|
16 |
3S |
p. e38
|
article
|
| 16 |
Coronary Computed Tomography Angiography Evaluation of Plaque Morphology and Its Relationship to HDL and Total Cholesterol to HDL Ratio
|
Manubolu, Venkat S.
|
|
|
16 |
3S |
p. e55
|
article
|
| 17 |
†Does Cholesterol Screening in Prader Willi Syndrome Represent an Opportunity to Reduce Cardiovascular Disease Risk?
|
Roy, Sani
|
|
|
16 |
3S |
p. e59-e60
|
article
|
| 18 |
*Effects of Icosapent Ethyl on Plasma Ceramides and Coronary Plaque Progression in EVAPORATE trial
|
Lakshmanan, S
|
|
|
16 |
3S |
p. e39
|
article
|
| 19 |
†Efficacy and Safety of Bempedoic Acid in Patients with Metabolic Syndrome
|
Taub, Pam
|
|
|
16 |
3S |
p. e57-e58
|
article
|
| 20 |
†Efficacy and Safety of Inclisiran in Patients with Established Cerebrovascular Disease: Pooled Post hoc Analysis of the Phase 3 ORION-9, ORION-10, and ORION-11 Randomized Controlled Trials
|
Ray, Kausik
|
|
|
16 |
3S |
p. e65
|
article
|
| 21 |
†Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled Post hoc Analysis of the phase 3 ORION-9, ORION-10, and ORION-11 Randomized Controlled Trials
|
Ray, Kausik
|
|
|
16 |
3S |
p. e63
|
article
|
| 22 |
Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particles
|
Mason, R.
|
|
|
16 |
3S |
p. e55-e56
|
article
|
| 23 |
Genetic Architecture and Cardiovascular Risk of Familial Combined Hyperlipidemia
|
Trinder, Mark
|
|
|
16 |
3S |
p. e48
|
article
|
| 24 |
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine
|
Hadley, Trevor
|
|
|
16 |
3S |
p. e50
|
article
|
| 25 |
GOULD EDU: Primary Results of a Cluster-Randomized Trial of an Educational Intervention to Improve Guideline Adherence and Intensification of Lipid-Lowering Therapy
|
Ballantyne, Christie
|
|
|
16 |
3S |
p. e37-e38
|
article
|
| 26 |
Impact of Telehealth on the Current and Future Practice of Lipidology: A Scoping Review
|
Desai, Nihar
|
|
|
16 |
3S |
p. e36
|
article
|
| 27 |
Improvement in Housestaff Knowledge of Novel Antihyperglycemic Agents Through a Cross-Specialty Beyond Diabetes“Educational Initiative”
|
Hmoud, Hosam
|
|
|
16 |
3S |
p. e70
|
article
|
| 28 |
Intima-media Thickness Measured at the Common-carotid Artery in Patients Treated with Lipoprotein Apheresis
|
Thompson, W Jake
|
|
|
16 |
3S |
p. e46
|
article
|
| 29 |
Intracoronary Thrombus in a Patient with Elevated Lp(a) Levels and COVID-19
|
Echeverry, Tatiana
|
|
|
16 |
3S |
p. e39-e40
|
article
|
| 30 |
*Ketogenic Diets Exacerbating Hypercholesterolemia in APOE Variants and APOB Mutations-Potential Role for Measuring Intestinal Absorption of Lipids
|
Omar, Alaa
|
|
|
16 |
3S |
p. e60-e61
|
article
|
| 31 |
Lipid-Lowering Therapy for Primary Prevention of Cardiovascular Disease: A Nationwide Analysis of 440,721 Patients
|
Peterson, Eric
|
|
|
16 |
3S |
p. e69-e70
|
article
|
| 32 |
*Lipoprotein X hyperlipidemia and Its Complications in a Patient with Primary Sclerosing Cholangitis
|
Soffer, Daniel
|
|
|
16 |
3S |
p. e43
|
article
|
| 33 |
Management of Atherogenic Dyslipidemia in a Patient with LDL Discordance
|
Jacoby, Douglas
|
|
|
16 |
3S |
p. e60
|
article
|
| 34 |
Marked Hypoleptinemia precedes Overt Fat Loss in Immune Checkpoint Inhibitor-induced Acquired Generalized Lipodystrophy
|
Sandooja, Rashi
|
|
|
16 |
3S |
p. e42
|
article
|
| 35 |
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse
|
Sen, Sabyasachi
|
|
|
16 |
3S |
p. e72
|
article
|
| 36 |
Mysterious Case of Reduction in HDL Cholesterol in a Patient with B-cell Monocytosis
|
Soffer, Daniel
|
|
|
16 |
3S |
p. e45
|
article
|
| 37 |
Novel Use of Therapeutic Plasma Exchange and Evinacumab in a Patient with Homozygous Familial Hypercholesterolemia
|
Sanchez, Amber
|
|
|
16 |
3S |
p. e40-e41
|
article
|
| 38 |
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial
|
Ditmarsch, Marc
|
|
|
16 |
3S |
p. e67-e68
|
article
|
| 39 |
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial
|
Kling, Douglas
|
|
|
16 |
3S |
p. e73
|
article
|
| 40 |
†Pharmacokinetics, Pharmacodynamics, and Safety of Bempedoic Acid in a Phase 1 Clinical Trial in Healthy Japanese, Chinese, and White subjects
|
Teng, Rujun
|
|
|
16 |
3S |
p. e68-e69
|
article
|
| 41 |
Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua
|
Salafia, Carolyn
|
|
|
16 |
3S |
p. e75
|
article
|
| 42 |
Racial Difference in Hypertriglyceridemia and Its Impact on Coronary Heart Diseases
|
Konindala, Navya
|
|
|
16 |
3S |
p. e62
|
article
|
| 43 |
Rate of 30-day Readmission & Economic Burden of Patients with Acute Congestive Heart Failure with Co-existing Metabolic Syndrome
|
Pereira, Leanne
|
|
|
16 |
3S |
p. e71-e72
|
article
|
| 44 |
†Safety and Efficacy of Bempedoic Acid in Patients with Hypertension
|
Michos, Erin
|
|
|
16 |
3S |
p. e56-e57
|
article
|
| 45 |
†Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment
|
Catapano, Alberico
|
|
|
16 |
3S |
p. e56
|
article
|
| 46 |
Severe Hypertriglyceridemia as a Cause of Arterial Thrombosis with Peripheral Embolic Complications.
|
Gupta, Kamal
|
|
|
16 |
3S |
p. e41-e42
|
article
|
| 47 |
^Sex Disparities in the Treatment and Outcomes of Familial Hypercholesterolemia
|
Guerin, Amanda
|
|
|
16 |
3S |
p. e51-e52
|
article
|
| 48 |
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database
|
Konindala, Navya
|
|
|
16 |
3S |
p. e61
|
article
|
| 49 |
The Effect of Estrogen and Testosterone on Cholesterol Crystallization
|
Al-abcha, Abdullah
|
|
|
16 |
3S |
p. e75-e76
|
article
|
| 50 |
The NLRP3 inhibitor and Nrf2 Agonist, RRx-001, Ameliorates Non-alcoholic Fatty Liver Disease in Rats
|
Caroen, Scott
|
|
|
16 |
3S |
p. e69
|
article
|
| 51 |
Unique Case of Management of Severe Hypertriglyceridemia Secondary to Familial Chylomicronemia Syndrome
|
Rader, Daniel
|
|
|
16 |
3S |
p. e74
|
article
|
| 52 |
Universal Screening for Familial Hypercholesterolemia in Two Populations
|
Sustar, Ursa
|
|
|
16 |
3S |
p. e52
|
article
|
| 53 |
Unveiling Compound Heterozygous Familial Hypercholesterolemia
|
Soffer, Daniel
|
|
|
16 |
3S |
p. e49
|
article
|
| 54 |
Why Are Patients Presenting with STEMI Already on Statin Not Treated with Additional Aggressive Lipid-lowering Agents?
|
Zirille, Francis
|
|
|
16 |
3S |
p. e38-e39
|
article
|
Journal description